Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Nov 17;13:11795–11806. doi: 10.2147/OTT.S274492

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Yang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

miR-647 is partially responsible for ZFAS1-mediated malignant phenotypes of CC. (A) The miR-647 mimics were transfected into ZFAS1-overexpressed Hela cells. (B) The miR-647 overexpression attenuated the proliferation promotion mediated by ZFAS1 in Hela cells. (C) The miR-647 overexpression attenuated the migration and invasion promotion mediated by ZFAS1 in Hela cells. (D) The miR-647 inhibitors were transfected into ZFAS1-silenced Caski cells. (E) The miR-647 knockdown partly restored the proliferation suppression mediated by ZFAS1 knockdown in Caski cells. (F) The miR-647 knockdown partly restored the migration and invasion suppression mediated by ZFAS1 knockdown in Caski cells.*p<0.05, **p<0.01.